Hear from an expert about self-collection in a healthcare setting

Be at the forefront of cervical cancer screening with BD Onclarity™ HVP Assay, the first and only FDA-approved HPV assay offering both extended genotyping and self-collection in a healthcare setting.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD Onclarity HPV Assay
Cervical Cancer | News & Updates
Press Release: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
ReachMD: A review of risk in cervical cancer: An analysis of the ASCCP guidelines & NCI risk matrix
Cervical Cancer | Webinars & Videos
ReachMD: A review of risk in cervical cancer: An analysis of the ASCCP guidelines & NCI risk matrix
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Cervical Cancer | News & Updates
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?